Follicum is a pharmaceutical company. The greatest focus is on the development of drug candidates that stimulate hair growth in patients. Currently products are held that may stimulate hair growth, but also hamper the degree of hair growth, mainly derived from hirsutism, which implicates unusually large production of hair in women. The pharmaceutical consists of endogenous, human proteins, which influence the processing of hair follicles. The company was established in 2011 and is based in Lund.

Quotes for Follicum AB

Right Now

+/-
-0.005
%
-1,22%
Latest
0.405
High
0.462
Low
0.402
Volume
191 144
Turnover (SEK)
78 306
Value (MSEK)
33,1

Board

CEO

  • Jonas Edelswärd (tf)

Chairperson of the Board

  • Gun-Britt Fransson

Board

  • Alejandra Mørk
  • Carl-Johan Spak
  • Lars H. Bruzelius

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 7,66 7,66 2021-09-30
Recipharm Venture Fund AB 5,34 5,34 2021-09-30
Mats Paulssons Stiftelse För Forskning Innovation Samhällsbygg 3,92 3,92 2021-09-30
Brushamn Invest AB 3,42 3,42 2021-09-30
Tibia Konsult AB 3,38 3,38 2021-09-30
Dan Peters 3,04 3,04 2021-09-30
Mats Lundberg 2,67 2,67 2021-09-30
Rothesay Ltd 2,45 2,45 2020-12-31
Nordnet Pensionsförsäkring 2,10 2,10 2021-09-30
Pia Althin 2,02 2,02 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream